Fact CheckerSign in

NCT07824661Completed

Impact of Cessation of Toothpaste in Patients With Migraine Headaches

A Randomized Controlled Pilot Exploratory Study on the Impact of Cessation of Toothpaste in Patients With Migraine Headaches

Source: ClinicalTrials.gov · Last updated 25 Sept 2026

Brief summary (registry, in English)

Certain ingredients in toothpaste have the potential to cause headache. In this clinical trial, the investigators will be replacing toothpaste with saline water in a group of persons with migraine and compare them with another group of persons with migraine who will continue the use of toothpaste. Both the groups will have the same treatment protocol with the only difference being the intervention of changing the toothpaste with saline. This study will show whether this lifestyle intervention can improve headache frequency in persons with migraine over a four week period.

Status (registry)
Completed
Study type
Interventional
Enrollment
106 (actual)
First submitted
11 Sept 2026
Start date
17 Feb 2025
Primary completion date
15 Jun 2025
Lead sponsor
St.John's National Academy of Health Sciences
Diseases
Migraine
NCT number
NCT07824661

What you commit to

  • Study type: Interventional
  • Participants enrolled: 106
  • From 17 Feb 2025 to the primary completion date, 15 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with a history of hemiplegic migraine, cluster headache, and other trigeminal autonomic cephalalgias, and secondary headaches will be excluded.

Who the study is looking for

  • Adults 18-59 years of age who had migraine with or without aura and who were not on any prophylactic medicines will be enrolled for participation in the study. Migraine is defined in accordance with the International Classification of Headache Disorders, 3rd Edition (ICHD3).

Age in the registry: 18 years to 59 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
St. John's Medical College Hospital
Coordinator of this site? Confirm its status
BengaluruIndiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.